The present invention provides methods of enforcing expression of an E-selectin and/or L-selectin ligand on a surface of a cell. Also provided are methods of enabling and/or increasing binding of a cell to E-selectin and/or L-selectin, methods of increasing homing and/or extravasation in a population of transplanted cells, methods of producing modified cells, including stem cells, for transplanting into a subject, methods of treating or ameliorating the effects of a symptom, a disease or an injury in a subject, and methods for inducing and/or enhancing homing of a population of cells to a therapeutic target in a subject. The invention further provides pharmaceutical compositions comprising a population of cells produced by the methods of the invention and kits that include such compositions for treating or ameliorating the effects of a symptom, a disease or an injury in a subject.
